These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7758554

  • 1. Atrial natriuretic peptide in acute hypoxia-exposed healthy subjects and in hypoxaemic patients.
    Lordick F, Hauck RW, Senekowitsch R, Emslander HP.
    Eur Respir J; 1995 Feb; 8(2):216-21. PubMed ID: 7758554
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide in primary pulmonary hypertension.
    Morice AH, Pepke-Zaba J, Brown MJ, Thomas PS, Higenbottam TW.
    Eur Respir J; 1990 Sep; 3(8):910-3. PubMed ID: 2149841
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of atrial natriuretic peptide under acute hypoxia in normal subjects.
    Kawashima A, Kubo K, Hirai K, Yoshikawa S, Matsuzawa Y, Kobayashi T.
    Respir Physiol; 1989 Apr; 76(1):79-91. PubMed ID: 2524868
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension.
    Adnot S, Chabrier PE, Andrivet P, Viossat I, Piquet J, Brun-Buisson C, Gutkowska Y, Braquet P.
    Am Rev Respir Dis; 1987 Oct; 136(4):951-6. PubMed ID: 2959183
    [Abstract] [Full Text] [Related]

  • 5. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.
    Cargill RI, Lipworth BJ.
    Br J Clin Pharmacol; 1995 Dec; 40(6):585-90. PubMed ID: 8703666
    [Abstract] [Full Text] [Related]

  • 6. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N, Nishikimi T, Uematsu M, Kyotani S, Satoh T, Nakanishi N, Matsuo H, Kangawa K.
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [Abstract] [Full Text] [Related]

  • 7. Atrial natriuretic peptide during and after maximal and submaximal exercise under normoxic and hypoxic conditions.
    Schmidt W, Brabant G, Kröger C, Strauch S, Hilgendorf A.
    Eur J Appl Physiol Occup Physiol; 1990 Aug; 61(5-6):398-407. PubMed ID: 2150372
    [Abstract] [Full Text] [Related]

  • 8. Plasma endothelin-1 level in chronic obstructive pulmonary disease: relationship with natriuretic peptide.
    Fujii T, Otsuka T, Tanaka S, Kanazawa H, Hirata K, Kohno M, Kurihara N, Yoshikawa J.
    Respiration; 1999 Aug; 66(3):212-9. PubMed ID: 10364736
    [Abstract] [Full Text] [Related]

  • 9. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.
    Jin H, Yang RH, Chen YF, Jackson RM, Oparil S.
    J Clin Invest; 1990 Jan; 85(1):115-20. PubMed ID: 2136863
    [Abstract] [Full Text] [Related]

  • 10. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J.
    Int J Cardiol; 2005 Oct 20; 105(1):31-9. PubMed ID: 16207542
    [Abstract] [Full Text] [Related]

  • 11. Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats.
    Jin H, Chen YF, Yang RH, Jackson RM, Oparil S.
    J Appl Physiol (1985); 1990 Jun 20; 68(6):2413-8. PubMed ID: 2166736
    [Abstract] [Full Text] [Related]

  • 12. Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats.
    Jin HK, Yang RH, Thornton RM, Chen YF, Jackson R, Oparil S.
    J Appl Physiol (1985); 1988 Oct 20; 65(4):1729-35. PubMed ID: 2972675
    [Abstract] [Full Text] [Related]

  • 13. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP.
    Klinger JR, Petit RD, Curtin LA, Warburton RR, Wrenn DS, Steinhelper ME, Field LJ, Hill NS.
    J Appl Physiol (1985); 1993 Jul 20; 75(1):198-205. PubMed ID: 7690745
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen.
    Winter RJ, Davidson AC, Treacher D, Rudd RM, Anderson JV, Meleagros L, Bloom SR.
    Thorax; 1989 Jan 20; 44(1):58-62. PubMed ID: 2522688
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.
    Wiedemann R, Ghofrani HA, Weissmann N, Schermuly R, Quanz K, Grimminger F, Seeger W, Olschewski H.
    J Am Coll Cardiol; 2001 Oct 20; 38(4):1130-6. PubMed ID: 11583893
    [Abstract] [Full Text] [Related]

  • 16. Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia.
    Westendorp RG, Roos AN, van der Hoeven HG, Tjiong MY, Simons R, Frölich M, Souverijn JH, Meinders AE.
    Am Rev Respir Dis; 1993 Aug 20; 148(2):304-9. PubMed ID: 8393637
    [Abstract] [Full Text] [Related]

  • 17. The role of atrial natriuretic peptide and endothelin in hypoxia induced pulmonary hypertension.
    Chen YF, Li H, Elton TS, Yang RH, Jin H, Oparil S.
    Chin J Physiol; 1994 Aug 20; 37(3):165-83. PubMed ID: 7705179
    [Abstract] [Full Text] [Related]

  • 18. Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats.
    Jin H, Yang RH, Chen YF, Jackson RM, Itoh H, Mukoyama M, Nakao K, Imura H, Oparil S.
    J Appl Physiol (1985); 1991 Sep 20; 71(3):807-14. PubMed ID: 1661719
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide expression in rats with different pulmonary hypertensive responses to hypoxia.
    Klinger JR, Wrenn DS, Warburton RR, Pietras L, Ou LC, Hill NS.
    Am J Physiol; 1997 Jul 20; 273(1 Pt 2):H411-7. PubMed ID: 9249516
    [Abstract] [Full Text] [Related]

  • 20. Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats.
    Klinger JR, Warburton RR, Pietras L, Hill NS.
    J Appl Physiol (1985); 1998 May 20; 84(5):1646-52. PubMed ID: 9572812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.